This paper is only available as a PDF. To read, Please Download here.
Purpose Targeted muscle reinnervation (TMR) coapts amputated nerves to small motor
nerves to power a prosthetic limb. Additionally, clinical studies have shown TMR performed
within 3 months of major limb amputation prevents or reduces phantom and residual
limb pain. However, TMR delayed over 3 months is much less effective. We have previously
shown that TMR performed 3 weeks following SNI returned pain behaviors to baseline.
This study examined the effect of TMR performed at the time of TMR versus a delay
of 12 weeks following SNI to determine whether this model reflects clinical findings.
SNI was performed in male rats and interventions were applied at the time of SNI,
3 weeks, and 12 weeks following SNI. Pain behaviors were assessed with von Frey threshold,
pin testing, dynamic brush testing and acetone testing prior to intervention and at
1, 3, 6, and 12 weeks following intervention. Simple neuroma excision (NE) was used
as a control intervention. TMR performed immediately at the time of SNI prevented
the development of a pain phenotype. Animals tested 3 and 12 weeks following SNI showed
a robust pain phenotype: increased hyperalgesic responses, reduced Von Frey thresholds,
and increased cold sensitivity. TMR at 3 weeks following SNI successfully reversed
the pain behaviors to baseline. In contrast, if TMR or NE was delayed 12 weeks after
SNI, the pain behaviors persisted. The neuropathic pain phenotype generated by SNI
can be treated with TMR performed immediately and 3 weeks following development of
a pain phenotype. In contrast, delayed TMR provides no relief of pain behaviors. This
model closely corresponds to clinical experience in patients with limb amputation
and will facilitate further understanding of the mechanisms behind TMR and how the
intervention may be modified to help chronic amputation-related pain. Medical College
of Wisconsin Neurosciences Research Center Plastic Surgery Foundation- American Association
for Hand Surgery Pilot Grant 628811.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2021 Published by Elsevier Inc.